Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05162820 · ClinicalTrials.gov registry record · NA
Impact of Solarplast® on Immunity in Active Smokers and Non-smokers
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05162820 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 50 participants.
The verdict
NCT05162820, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of Solarplast treatment on measures of oxidative stress, immune function, skin appearance, and associated measures in 60 men and women, consisting of both cigarette smokers and nonsmokers. The hypothesis is that the Solarplast treatment will reduce oxidative stress biomarkers and favorably impact immune measures and both perceived and quantifiable measures of skin health, in both smokers and non-smokers, with a greater impact observed in smokers. Photographic analyses like the Pear Plus 3D system have been developed for clinical use for monitoring skin health.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 100 mg Solarplast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05162820
The ClinicalTrials.gov registry entry for NCT05162820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05162820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05162820 about?
NCT05162820 is a clinical study titled "Impact of Solarplast® on Immunity in Active Smokers and Non-smokers". The purpose of this study is to determine the impact of Solarplast treatment on measures of oxidative stress, immune function, skin appearance, and associated measures in 60 men and women, consisting of both cigarette smokers and nonsmokers. The hypothesis is that the Solarplast treatment will reduc...
What is the current status of trial NCT05162820?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-10-22. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT05162820?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 100 mg Solarplast (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05162820?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.